Could Brexit crush 5%+ yields at GlaxoSmithKline plc and at Admiral Group plc?

Would Brexit turmoil cause GlaxoSmithKline plc (LON:GSK) and Admiral Group plc (LON:ADM) to cut their dividend payouts?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The latest polls and betting odds suggest that the outcome of next week’s EU referendum will be very finely balanced. If you’re an income investor, it could be worth asking whether any of the dividends in your portfolio are likely to be affected by a Brexit.

Safe as houses?

Pharma giant GlaxoSmithKline (LSE: GSK) is a Neil Woodford favourite, and a fixture in many investors’ income portfolios. The stock’s current 5.7% forecast yield is well above the FTSE 100 average of 4%.

Glaxo shares have outperformed the market and made modest gains so far in 2016, as the outlook for the group has improved. Core earnings per share rose by 14% during the first quarter, compared to the same period last year.

Glaxo now expects full-year core earnings growth of between 10% and 12%, suggesting a full-year figure of about 85p per share. This should be enough to cover the firm’s guided dividend of 80p per share.

Although some risks remain for Glaxo shareholders, in my view Brexit isn’t one of them. Glaxo operates in most of the world’s major economies and currencies. The firm’s business is built around its portfolio of unique products, most of which have patent protection.

I can’t see any logical reason why a UK vote to leave the EU would be likely to have a material effect on Glaxo’s sales, or its ability to pay a reliable dividend. In my view, any short-term dips as a result of the referendum could be a good buying opportunity.

Will insurance be affected?

Shares in motor insurance group Admiral Group (LSE: ADM) have risen by 25% over the last year. The FTSE 100 has fallen by 11% over the same period, making Admiral a clear winner. But while Admiral’s shares surged higher following the group’s results in March, progress since then has been uncertain.

One reason for this may simply be that Admiral’s shares now look quite fully priced. Earnings per share are expected to be flat this year and to rise by a relatively modest 6% in 2017. Set against this level of growth, I think Admiral’s 2016 forecast P/E of 17.4 is probably high enough.

However, Brexit fears may also be playing a part. The group has insurance or price comparison businesses in France, Spain and Italy. None of these make much money for the group at the moment, but international expansion is a key part of Admiral’s growth strategy.

A Brexit vote could potentially make it harder for UK companies to run regulated financial businesses in Europe. Personally, I suspect this wouldn’t be a big issue, but it’s definitely a risk. We simply don’t know how an EU exit would be handled.

Given all of this, how safe is Admiral’s dividend? The firm’s total payout is expected to be 112.7p per share this year, giving a forecast yield of 6.2%.

My view is that while Admiral is banking on its European and US operations for future growth, the current dividend is funded by Admiral’s UK business. I don’t see any reason why a Brexit would have an immediate impact on Admiral’s dividend.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Can someone invest like Warren Buffett with a spare £500?

Christopher Ruane explains why an investor without the resources of billionaire Warren Buffett could still learn from his stock market…

Read more »

Investing Articles

Can these 2 incredible FTSE 250 dividend stocks fly even higher in 2026?

Mark Hartley examines the potential in two FTSE 250 shares that have had an excellent year and considers what 2026…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Is 45 too late to start investing?

Investing at different life stages can come with its own challenges -- and rewards. Our writer considers why a 45-year-old…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

UK shares look cheap — but the market might be about to take notice

UK shares have traded at a persistent discount to their US counterparts. This can create huge opportunities, but investors need…

Read more »

Investing Articles

This FTSE 100 growth machine is showing positive signs for a 2026 recovery

FTSE 100 distributor Bunzl is already the second-largest holding in Stephen Wright’s Stocks and Shares ISA. What should his next…

Read more »

Investing Articles

I asked ChatGPT for the best FTSE 100 stocks to buy for passive income in 2026 and it said…

Paul Summers wanted to learn which dividend stocks an AI bot thinks might be worth buying for 2026. Its response…

Read more »

ISA Individual Savings Account
Investing Articles

Stop missing out! A Stocks and Shares ISA could help you retire early

Investors who don't use a Stocks and Shares ISA get all the risks that come with investing but with less…

Read more »

Investing Articles

Will Greggs shares crash again in 2026?

After a horrible 2025, Paul Summers takes a look at whether Greggs shares could sink even further in price next…

Read more »